Life Science/

Disease panels

Sequencing of disease Panels with MiSeq or NextSeq 2000


StarSEQ offers a wide range of different disease panels based on Illumina™ or Agilent™ technology. We offer complete services starting from DNA or RNA extraction from different types of tissues. The following panels are available:

  • TruSight Oncology 500
  • TruSight Tumor 170
  • TruSight Hereditary Cancer Panel
  • TruSight Cardio
  • TruSight RNA Pan-Cancer panel
  • TruSight Cancer

  • ClearSeq Comprehensive Cancer
  • ClearSeq Human DNA Kinome
  • ClearSeq Human RNA Kinome
  • ClearSeq Inherited Disease
  • Clinical Research Exome

All Panels are For Research Use Only, Not for Use in Diagnostic Procedures.

TruSight Myeloid Sequencing Panel, the panel content was designed by a consortium of recognized experts in blood cancer disorders and targets genes frequently mutated in:

  • Acute myeloid leukemia (AML)
  • Myelodysplastic syndrome (MDS)
  • Myeloproliferative neoplasms (MPN)
  • Chronic myelogenous leukemia (CML)
  • Chronic myelomonocytic leukemia (CMML)
  • Juvenile myelomonocytic leukemia (JMML)

TruSight Tumor 170


TruSight Tumor 170, a next-generation sequencing assay designed to cover 170 genes associated with common solid tumors, is an enrichment-based targeted panel that simultaneously analyzes DNA and RNA, covering a wide range of genes and variant types. The comprehensive nature provides laboratories with a deep view into the genetics of cancer.

  • This field is for validation purposes and should be left unchanged.